MTOR and B-cell chronic lymphocytic leukemia: Supporting this, a significant inhibition of protein synthesis (OPP assay) was noted in primary CLL cells with mTOR inhibitor-containing treatments, while IB alone had no effect (Fig. 7D), and both combination treatments (RAP/IB and AZ/IB) significantly reduced primary CLL cell viability (Fig. 7E).